Company Introduction

Company introduction

Follitrope® Recombinant FSH, used in the treatment of female infertility in

controlled ovarian hyperstimulation to induce the development of
multiple follicles in a medically assisted reproduction program as well
LG Life Sciences, Ltd. as anovulation

Hyruan Plus® High molecular weight hyaluronic acid viscosupplement made by

microbial fermentation for low side-effect,
quality proven by EMEA and CE marking
The First Pioneer in Korean Pharmaceutical R&D
Products
R&D Pipelines
LG Life Sciences is Korea’s leading biopharmaceutical company.
One of LG Group affi liate, demerged from LG Chem in 2002. LGLS
is leveraging its proven R&D capabilities to develop world-class
products, Factive® , the only US FDA approved novel chemical
drug, as well as Valtropin® , the fi rst biosimilar approved by the
EMEA and US
FDA developed in Korea. LGLS is building a network of strategic
alliances to extend its R&D and marketing reach.

Products
Products Details * HA = Hyaluronic acid

Fast Active, the most potent quinolone

Factive® antibiotic in the world, commercialized in over
30 countries worldwide

A novel dipeptidyl peptidase IV (DPP IV)

inhibitor for T2DM with good efficacy and
Zemiglo®
safety profiles.
Approved by the KFDA in June, 2012
CEO The right choice for managing short stature
Il-Jae Jung Eutropin® recombinant human growth hormone with
Location proven efficacy and safety since 1993
LG Gwanghwamun Bldg. 92,
Sinmunno-2ga, Jongno-gu,
Seoul, Korea Human recombinant erythropoietin, safe and
Espogen® effective treatment for anemia of chronic
Homepage
www.lgls.com
renal failure

46 47